---
$id: https://graph.org.ai/products/commodity/51131728
$type: Product
source: UNSPSC
code: "51131728"
title: "Iliparcil"
class: "51131700"
classTitle: "Thrombolytic drugs and platelet aggregation inhibitors"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Iliparcil

**UNSPSC Code**: 51131728
**Class**: [Thrombolytic drugs and platelet aggregation inhibitors](Thrombolytic drugs and platelet aggregation inhibitors.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a thrombolytic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 753UJ7AGLA. European Medicines Agency schedules Iliparcil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08131MIG. Iliparcil generally arises in the molecular formula C15H15CLO6S. The term ILIPARCIL is an International Non-Proprietary Name or INN. ILIPARCIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule iliparcil under HS 29349990 and SITC 51579. As of Q4 2014, ILIPARCIL remains the US FDA Preferred Term for this commodity. Iliparcil bears US NLM identifiers UMLS ID C0909750 and NCI Concept Code C83783. SMILES: S1C(OC2CC3OC(=O)CC(C3CC2)CC)C(O)C(O)C(O)C1.

